Literature DB >> 11012764

T lymphocytes from granulocyte colony-stimulating factor-/- mice produce large quantities of interferon-gamma in a chronic infection model.

S I Mannering1, Y Zhan, B Gilbertson, G J Lieschke, C Cheers.   

Abstract

Little is known about the role of granulocyte colony-stimulating factor (G-CSF) in the response to chronic bacterial infections. To address this we infected G-CSF knock out (G-CSF-/-) mice with Mycobacterium avium. Infection was not exacerbated in G-CSF-/- mice despite a deficiency in the total bone marrow cells, colony-forming haemopoietic cells, granulocytes and monocyte precursors in the bone marrow. Peritoneal cells from G-CSF-/- produced less nitric oxide (NO) upon culture in vitro with antigen than did wild-type (WT) cells. Unexpectedly, T cells from infected G-CSF-/- mice were able to produce significantly more interferon-gamma (IFN-gamma) than the wild type (WT) controls. T cells from G-CSF-/- mice still produced more IFN-gamma even when in vitro NO production was inhibited, while enzyme-linked immunospot assay (ELISPOT) assays showed more IFN-gamma-producing cells in the G-CSF-/- mice. This was confirmed by intracellular cytokine staining (ICCS), which showed that there were more IFN-gamma producing T cells in vivo in the G-CSF-/- than the WT controls following M. avium infection. It is possible that a deficit of NO in vivo allows T cells to develop a higher IFN-gamma-producing phenotype. Thus we show a novel relationship between G-CSF and IFN-gamma production by T cells revealed in this chronic bacterial infection model.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012764      PMCID: PMC2327063          DOI: 10.1046/j.1365-2567.2000.00075.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Biological activities of recombinant human granulocyte colony stimulating factor (rhG-CSF) and tumor necrosis factor: in vivo and in vitro analysis.

Authors:  M A Moore; K Welte; J Gabrilove; L M Souza
Journal:  Haematol Blood Transfus       Date:  1987

2.  The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.

Authors:  R Appelberg; A M Sarmento
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

4.  Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances.

Authors:  C C Czerkinsky; A Tarkowski; L A Nilsson; O Ouchterlony; H Nygren; C Gretzer
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

5.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

6.  Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome.

Authors:  M A Yakrus; R C Good
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

7.  Stimulation of a T helper cell class 2 clone with immobilized anti-T cell receptor antibody activates a Ca2+ and protein kinase C-independent lethal signaling pathway.

Authors:  H M Cherwinski; G T Semenuk; J T Ransom
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

8.  Binding of 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells.

Authors:  N A Nicola; D Metcalf
Journal:  J Cell Physiol       Date:  1985-08       Impact factor: 6.384

9.  Inhibition of B lymphocyte activation by interferon-gamma.

Authors:  D S Reynolds; W H Boom; A K Abbas
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

10.  Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs.

Authors:  C Cheers; A M Haigh; A Kelso; D Metcalf; E R Stanley; A M Young
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more
  5 in total

1.  Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease.

Authors:  Evelyn Tsantikos; Maverick Lau; Cassandra Mn Castelino; Mhairi J Maxwell; Samantha L Passey; Michelle J Hansen; Narelle E McGregor; Natalie A Sims; Daniel P Steinfort; Louis B Irving; Gary P Anderson; Margaret L Hibbs
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

2.  Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans.

Authors:  Gerhard Wingender; Marcus Hiss; Isaac Engel; Konrad Peukert; Klaus Ley; Hermann Haller; Mitchell Kronenberg; Sibylle von Vietinghoff
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

3.  Induction of disseminated Mycobacterium avium in simian AIDS is dependent upon simian immunodeficiency virus strain and defective granuloma formation.

Authors:  K G Mansfield; R S Veazey; A Hancock; A Carville; M Elliott; K C Lin; A A Lackner
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium.

Authors:  Jason D Price; Kim R Simpfendorfer; Radhakrishnam R Mantena; James Holden; William R Heath; Nico van Rooijen; Richard A Strugnell; Odilia L C Wijburg
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

Review 5.  G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis.

Authors:  Ann L Cornish; Ian K Campbell; Brent S McKenzie; Simon Chatfield; Ian P Wicks
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.